AstraZeneca PLC (AZN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about AstraZeneca PLC (AZN)
Go deeper and ask any question about AZN
Company Performance
Current Price
as of Sep 17, 2024$158.27
P/E Ratio
36.32
Market Cap
$245.37B
Description
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Metrics
Overview
- HQCambridge, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAZN
- Price$158.271288-0.12%
Trading Information
- Market Cap$245.37B
- Float94.26%
- Average Daily Volume (1m)1,188,264
- Average Daily Volume (3m)1,203,638
- EPS$3.30
Company
- Revenue$39.03B
- Rev Growth (1yr)12.44%
- Net Income$1.53B
- Gross Margin75.69%
- EBITDA Margin31.84%
- EBITDA$3.26B
- EV$213.75B
- EV/Revenue5.48
- P/E36.32
- P/S4.78
Documents
Factset Street Account
Factset